V. Ralevic et Da. Kendall, Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission inthe rat mesenteric arterial bed, EUR J PHARM, 418(1-2), 2001, pp. 117-125
The present study investigated whether cannabinoids can modulate neurotrans
mission mediated by capsaicin-sensitive sensory nerves in the rat isolated
mesenteric arterial bed. Sensory neurogenic vasorelaxation mediated by elec
trical field stimulation was concentration-dependently attenuated by HU210
(0.1-3 muM), a cannabinoid receptor agonist (from 62 +/- 8.3% to 6 +/- 2.1%
at 3 muM HU210) I-fil210 had no effect on relaxation to exogenous calciton
in gene-related peptide, indicating a prejunctional action. The action of H
U210(I muM) was not affected by LY320135 (1 muM) or SR144528 (1 muM). canna
binoid CB1 and CB2 receptor antagonists, respectively. SR141716A (0.01-1 mu
M), a cannabinoid CB1 receptor antagonist, concentration-dependently augmen
ted vasorelaxation to electrical field stimulation, but had no effect on re
sponses to calcitonin gene-related peptide and capsaicin, indicating a poss
ible role of endogenous cannabinoids in sensory neurotransmission in rat me
senteric arteries. These data show that the cannabinoid receptor agonist HU
210 inhibits prejunctionally sensory neurotransmission in rat mesenteric ar
teries and that this action is independent of cannabinoid CB1- or CB2-like
receptors. (C) 2001 Elsevier Science B.V. All rights reserved.